Cowpox virus inhibits human dendritic cell immune function by nonlethal, nonproductive infection

Virology

Volumn 412, Issue 2, 2011, Pages 411-425

  Hansen, Spencer J ^a   Rushton, John ^a   Dekonenko, Alexander ^a   Chand, Hitendra S ^b   Olson, Gwyneth K ^a   Hutt, Julie A ^b   Pickup, David ^c   Lyons, C Rick ^a   Lipscomb, Mary F ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemokines; Cowpox virus; Cytokines; Dendritic cells; Immunosuppression; Mixed lymphocyte reaction; Myeloid dendritic cells; Orthopoxviruses; Plasmacytoid dendritic cells; Viral microarray

Indexed keywords

CHEMOKINE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR AGONIST; VIRUS PROTEIN;

ADAPTIVE IMMUNITY; ARTICLE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CELL STIMULATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; COWPOX VIRUS; DENDRITIC CELL; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MONOCYTE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SECRETION; UPREGULATION; VIRUS INFECTION; VIRUS INHIBITION;

CELL SURVIVAL; CELLS, CULTURED; COWPOX VIRUS; CYTOKINES; DENDRITIC CELLS; HUMANS; IMMUNE EVASION; NF-KAPPA B;

COWPOX VIRUS; ORTHOPOXVIRUS;

EID: 79952617960     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.01.024     Document Type: Article

References (111)

1. Al-Alwan M.M., Rowden G., Lee T.D., West K.A. The dendritic cell cytoskeleton is critical for the formation of the immunological synapse. J. Immunol. 2001, 166(3):1452-1456.
2. Alzhanova D., Edwards D.M., Hammarlund E., Scholz I.G., Horst D., Wagner M.J., Upton C., Wiertz E.J., Slifka M.K., Fruh K. Cowpox virus inhibits the transporter associated with antigen processing to evade T cell recognition. Cell Host Microbe 2009, 6(5):433-445.
3. Ardeshna K.M., Pizzey A.R., Devereux S., Khwaja A. The PI3 kinase, p38 SAP kinase, and NF-kappaB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells. Blood 2000, 96(3):1039-1046.
4. Assarsson E., Greenbaum J.A., Sundstrom M., Schaffer L., Hammond J.A., Pasquetto V., Oseroff C., Hendrickson R.C., Lefkowitz E.J., Tscharke D.C., Sidney J., Grey H.M., Head S.R., Peters B., Sette A. Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes. Proc. Natl Acad. Sci. USA 2008, 105(6):2140-2145.
5. Bauer M., Redecke V., Ellwart J.W., Scherer B., Kremer J.P., Wagner H., Lipford G.B. Bacterial CpG-DNA triggers activation and maturation of human CD11c-, CD123+ dendritic cells. J. Immunol. 2001, 166(8):5000-5007.
6. Bennett M., Crouch A.J., Begon M., Duffy B., Feore S., Gaskell R.M., Kelly D.F., McCracken C.M., Vicary L., Baxby D. Cowpox in British voles and mice. J. Comp. Pathol. 1997, 116(1):35-44.
7. Bonini C., Lee S.P., Riddell S.R., Greenberg P.D. Targeting antigen in mature dendritic cells for simultaneous stimulation of CD4+ and CD8+ T cells. J. Immunol. 2001, 166(8):5250-5257.
8. Born T.L., Morrison L.A., Esteban D.J., VandenBos T., Thebeau L.G., Chen N., Spriggs M.K., Sims J.E., Buller R.M. A poxvirus protein that binds to and inactivates IL-18, and inhibits NK cell response. J. Immunol. 2000, 164(6):3246-3254.
9. Borovkov A., Magee D.M., Loskutov A., Cano J.A., Selinsky C., Zsemlye J., Lyons C.R., Sykes K. New classes of orthopoxvirus vaccine candidates by functionally screening a synthetic library for protective antigens. Virology 2009, 395(1):97-113.
10. Boshkov L.K., Macen J.L., McFadden G. Virus-induced loss of class I MHC antigens from the surface of cells infected with myxoma virus and malignant rabbit fibroma virus. J. Immunol. 1992, 148(3):881-887.
11. Bowie A., Kiss-Toth E., Symons J., Smith G., Dower S., O'Neill L. A 46R and A52R from vaccinia virus are antagonists of host IL-1 and toll like receptor signaling. Proc. Natl Acad. Sci. USA 2000, 97:10162-10167.
12. Brandler S., Lepelley A., Desdouits M., Guivel-Benhassine F., Ceccaldi P.E., Levy Y., Schwartz O., Moris A. Preclinical studies of a modified vaccinia virus Ankara-based HIV candidate vaccine: antigen presentation and antiviral effect. J. Virol. 2010, 84(10):5314-5328.
13. Bronte V., Carroll M.W., Goletz T.J., Wang M., Overwijk W.W., Marincola F., Rosenberg S.A., Moss B., Restifo N.P. Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine. Proc. Natl Acad. Sci. USA 1997, 94(7):3183-3188.
14. Brum L.M., Turner P.C., Devick H., Baquero M.T., Moyer R.W. Plasma membrane localization and fusion inhibitory activity of the cowpox virus serpin SPI-3 require a functional signal sequence and the virus encoded hemagglutinin. Virology 2003, 306(2):289-302.
15. Bugert J.J., Darai G. Poxvirus homologues of cellular genes. Virus Genes 2000, 21(1-2):111-133.
16. Byun M., Wang X., Pak M., Hansen T.H., Yokoyama W.M. Cowpox virus exploits the endoplasmic reticulum retention pathway to inhibit MHC class I transport to the cell surface. Cell Host Microbe 2007, 2(5):306-315.
17. Byun M., Verweij M.C., Pickup D.J., Wiertz E.J., Hansen T.H., Yokoyama W.M. Two mechanistically distinct immune evasion proteins of cowpox virus combine to avoid antiviral CD8 T cells. Cell Host Microbe 2009, 6(5):422-432.
18. Chahroudi A., Chavan R., Kozyr N., Waller E.K., Silvestri G., Feinberg M.B. Vaccinia virus tropism for primary hematolymphoid cells is determined by restricted expression of a unique virus receptor. J. Virol. 2005, 79(16):10397-10407.
19. Chahroudi A., Garber D.A., Reeves P., Liu L., Kalman D., Feinberg M.B. Differences and similarities in viral life cycle progression and host cell physiology after infection of human dendritic cells with modified vaccinia virus Ankara and vaccinia virus. J. Virol. 2006, 80(17):8469-8481.
20. Chang S.J., Hsiao J.C., Sonnberg S., Chiang C.T., Yang M.H., Tzou D.L., Mercer A.A., Chang W. Poxvirus host range protein CP77 contains an F-box-like domain that is necessary to suppress NF-kappaB activation by tumor necrosis factor alpha but is independent of its host range function. J. Virol. 2009, 83(9):4140-4152.
21. Chantrey J., Meyer H., Baxby D., Begon M., Bown K.J., Hazel S.M., Jones T., Montgomery W.I., Bennett M. Cowpox: reservoir hosts and geographic range. Epidemiol. Infect. 1999, 122(3):455-460.
22. Chen R.A., Ryzhakov G., Cooray S., Randow F., Smith G.L. Inhibition of IkappaB kinase by vaccinia virus virulence factor B14. PLoS Pathog. 2008, 4(2):e22.
23. Chomarat P., Dantin C., Bennett L., Banchereau J., Palucka A.K. TNF skews monocyte differentiation from macrophages to dendritic cells. J. Immunol. 2003, 171(5):2262-2269.
24. Colamonici O.R., Domanski P., Sweitzer S.M., Larner A., Buller R.M. Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon alpha transmembrane signaling. J. Biol. Chem. 1995, 270(27):15974-15978.
25. Crouch A.C., Baxby D., McCracken C.M., Gaskell R.M., Bennett M. Serological evidence for the reservoir hosts of cowpox virus in British wildlife. Epidemiol. Infect. 1995, 115(1):185-191.
26. Cudmore S., Cossart P., Griffiths G., Way M. Actin-based motility of vaccinia virus. Nature 1995, 378(6557):636-638.
27. Dasgupta A., Hammarlund E., Slifka M.K., Fruh K. Cowpox virus evades CTL recognition and inhibits the intracellular transport of MHC class I molecules. J. Immunol. 2007, 178(3):1654-1661.
28. Delaloye J., Roger T., Steiner-Tardivel Q.G., Le Roy D., Knaup Reymond M., Akira S., Petrilli V., Gomez C.E., Perdiguero B., Tschopp J., Pantaleo G., Esteban M., Calandra T. Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome. PLoS Pathog. 2009, 5(6):e1000480.
29. Deng L., Dai P., Ding W., Granstein R.D., Shuman S. Vaccinia virus infection attenuates innate immune responses and antigen presentation by epidermal dendritic cells. J. Virol. 2006, 80(20):9977-9987.
30. Diebold S.S., Kaisho T., Hemmi H., Akira S., Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004, 303(5663):1529-1531.
31. DiPerna G., Stack J., Bowie A.G., Boyd A., Kotwal G., Zhang Z., Arvikar S., Latz E., Fitzgerald K.A., Marshall W.L. Poxvirus protein N1L targets the I-kappaB kinase complex, inhibits signaling to NF-kappaB by the tumor necrosis factor superfamily of receptors, and inhibits NF-kappaB and IRF3 signaling by toll-like receptors. J. Biol. Chem. 2004, 279(35):36570-36578.
32. Drillien R., Spehner D., Kirn A. Host range restriction of vaccinia virus in Chinese hamster ovary cells: relationship to shutoff of protein synthesis. J. Virol. 1978, 28(3):843-850.
33. Drillien R., Spehner D., Bohbot A., Hanau D. Vaccinia virus-related events and phenotypic changes after infection of dendritic cells derived from human monocytes. Virology 2000, 268(2):471-481.
34. Drillien R., Spehner D., Hanau D. Modified vaccinia virus Ankara induces moderate activation of human dendritic cells. J. Gen. Virol. 2004, 85(Pt 8):2167-2175.
35. Dzionek A., Fuchs A., Schmidt P., Cremer S., Zysk M., Miltenyi S., Buck D.W., Schmitz J. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J. Immunol. 2000, 165(11):6037-6046.
36. Engelmayer J., Larsson M., Subklewe M., Chahroudi A., Cox W.I., Steinman R.M., Bhardwaj N. Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. J. Immunol. 1999, 163(12):6762-6768.
37. Essbauer S., Pfeffer M., Meyer H. Zoonotic poxviruses. Vet. Microbiol. 2010, 140(3-4):229-236.
38. Gedey R., Jin X.L., Hinthong O., Shisler J.L. Poxviral regulation of the host NF-kappaB response: the vaccinia virus M2L protein inhibits induction of NF-kappaB activation via an ERK2 pathway in virus-infected human embryonic kidney cells. J. Virol. 2006, 80(17):8676-8685.
39. Graham S.C., Bahar M.W., Cooray S., Chen R.A., Whalen D.M., Abrescia N.G., Alderton D., Owens R.J., Stuart D.I., Smith G.L., Grimes J.M. Vaccinia virus proteins A52 and B14 Share a Bcl-2-like fold but have evolved to inhibit NF-kappaB rather than apoptosis. PLoS Pathog. 2008, 4(8):e1000128.
40. Gubser C., Hue S., Kellam P., Smith G.L. Poxvirus genomes: a phylogenetic analysis. J. Gen. Virol. 2004, 85(Pt 1):105-117.
41. Haga I.R., Bowie A.G. Evasion of innate immunity by vaccinia virus. Parasitology 2005, 130(Suppl):S11-S25.
42. Harper J.M., Parsonage M.T., Pelham H.R., Darby G. Heat inactivation of vaccinia virus particle-associated functions: properties of heated particles in vivo and in vitro. J. Virol. 1978, 26(3):646-659.
43. Harte M.T., Haga I.R., Maloney G., Gray P., Reading P.C., Bartlett N.W., Smith G.L., Bowie A., O'Neill L.A. The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense. J. Exp. Med. 2003, 197(3):343-351.
44. Hornung V., Ablasser A., Charrel-Dennis M., Bauernfeind F., Horvath G., Caffrey D.R., Latz E., Fitzgerald K.A. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 2009, 458(7237):514-518.
45. Hu F.Q., Smith C.A., Pickup D.J. Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor. Virology 1994, 204(1):343-356.
46. Hutchens M.A., Luker K.E., Sonstein J., Nunez G., Curtis J.L., Luker G.D. Protective effect of Toll-like receptor 4 in pulmonary vaccinia infection. PLoS Pathog. 2008, 4(9):e1000153.
47. Ichihashi Y., Dales S. Biogenesis of poxviruses: interrelationship between hemagglutinin production and polykaryocytosis. Virology 1971, 46(3):533-543.
48. Jaksits S., Bauer W., Kriehuber E., Zeyda M., Stulnig T.M., Stingl G., Fiebiger E., Maurer D. Lipid raft-associated GTPase signaling controls morphology and CD8+ T cell stimulatory capacity of human dendritic cells. J. Immunol. 2004, 173(3):1628-1639.
49. Jenne L., Hauser C., Arrighi J.F., Saurat J.H., Hugin A.W. Poxvirus as a vector to transduce human dendritic cells for immunotherapy: abortive infection but reduced APC function. Gene Ther. 2000, 7(18):1575-1583.
50. Jenne L., Thumann P., Steinkasserer A. Interaction of large DNA viruses with dendritic cells. Immunobiology 2001, 204(5):639-648.
51. Johnston J.B., Barrett J.W., Nazarian S.H., Goodwin M., Ricciuto D., Wang G., McFadden G. A poxvirus-encoded pyrin domain protein interacts with ASC-1 to inhibit host inflammatory and apoptotic responses to infection. Immunity 2005, 23(6):587-598.
52. Joklik W.K. The purification fo four strains of poxvirus. Virology 1962, 18:9-18.
53. Kadowaki N., Antonenko S., Lau J.Y., Liu Y.J. Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J. Exp. Med. 2000, 192(2):219-226.
54. Kaisho T., Akira S. Regulation of dendritic cell function through toll-like receptors. Curr. Mol. Med. 2003, 3(8):759-771.
55. Knight J.C., Goldsmith C.S., Tamin A., Regnery R.L., Regnery D.C., Esposito J.J. Further analyses of the orthopoxviruses volepox virus and raccoon poxvirus. Virology 1992, 190(1):423-433.
56. Larsson M., Fonteneau J.F., Somersan S., Sanders C., Bickham K., Thomas E.K., Mahnke K., Bhardwaj N. Efficiency of cross presentation of vaccinia virus-derived antigens by human dendritic cells. Eur. J. Immunol. 2001, 31(12):3432-3442.
57. Law K.M., Smith G.L. A vaccinia serine protease inhibitor which prevents virus-induced cell fusion. J. Gen. Virol. 1992, 73(Pt 3):549-557.
58. Lee J., Mo J.H., Katakura K., Alkalay I., Rucker A.N., Liu Y.T., Lee H.K., Shen C., Cojocaru G., Shenouda S., Kagnoff M., Eckmann L., Ben-Neriah Y., Raz E. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat. Cell Biol. 2006, 8(12):1327-1336.
59. Li P., Wang N., Zhou D., Yee C.S., Chang C.H., Brutkiewicz R.R., Blum J.S. Disruption of MHC class II-restricted antigen presentation by vaccinia virus. J. Immunol. 2005, 175(10):6481-6488.
60. Lipscomb M.F., Masten B.J. Dendritic cells: immune regulators in health and disease. Physiol. Rev. 2002, 82(1):97-130.
61. Liu Y.J., Kanzler H., Soumelis V., Gilliet M. Dendritic cell lineage, plasticity and cross-regulation. Nat. Immunol. 2001, 2(7):585-589.
62. Liu L., Xu Z., Fuhlbrigge R.C., Pena-Cruz V., Lieberman J., Kupper T.S. Vaccinia virus induces strong immunoregulatory cytokine production in healthy human epidermal keratinocytes: a novel strategy for immune evasion. J. Virol. 2005, 79(12):7363-7370.
63. Liu L., Chavan R., Feinberg M.B. Dendritic cells are preferentially targeted among hematolymphocytes by Modified Vaccinia Virus Ankara and play a key role in the induction of virus-specific T cell responses in vivo. BMC Immunol. 2008, 9:15.
64. Loparev V., Parsons J., Knight J., Panus J., Ray C., Buller R., Pickup D.J., Espisito J. A third distinct tumor necrosis factor receptor of orthopoxviruses. Proc. Natl Acad. Sci. USA 1998, 95:3786-3791.
65. Lynch H.E., Ray C.A., Oie K.L., Pollara J.J., Petty I.T., Sadler A.J., Williams B.R., Pickup D.J. Modified vaccinia virus Ankara can activate NF-kappaB transcription factors through a double-stranded RNA-activated protein kinase (PKR)-dependent pathway during the early phase of virus replication. Virology 2009, 391(2):177-186.
66. Martinez J., Huang X., Yang Y. Toll-like receptor 8-mediated activation of murine plasmacytoid dendritic cells by vaccinia viral DNA. Proc. Natl Acad. Sci. USA 2010, 107(14):6442-6447.
67. Masten B.J., Olson G.K., Tarleton C.A., Rund C., Schuyler M., Mehran R., Archibeque T., Lipscomb M.F. Characterization of myeloid and plasmacytoid dendritic cells in human lung. J. Immunol. 2006, 177(11):7784-7793.
68. Mentzer S.J., Guyre P.M., Burakoff S.J., Faller D.V. Spontaneous aggregation as a mechanism for human monocyte purification. Cell. Immunol. 1986, 101(2):312-319.
69. Mercer J., Helenius A. Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. Science 2008, 320(5875):531-535.
70. Meyer H., Neubauer H., Pfeffer M. Amplification of 'variola virus-specific' sequences in German cowpox virus isolates. J. Vet. Med. B Infect. Dis. Vet. Public Health 2002, 49(1):17-19.
71. Mohamed M.R., Rahman M.M., Lanchbury J.S., Shattuck D., Neff C., Dufford M., van Buuren N., Fagan K., Barry M., Smith S., Damon I., McFadden G. Proteomic screening of variola virus reveals a unique NF-kappaB inhibitor that is highly conserved among pathogenic orthopoxviruses. Proc. Natl Acad. Sci. USA 2009, 106(22):9045-9050.
72. Mohamed M.R., Rahman M.M., Rice A., Moyer R.W., Werden S.J., McFadden G. Cowpox virus expresses a novel ankyrin repeat NF-kappaB inhibitor that controls inflammatory cell influx into virus-infected tissues and is critical for virus pathogenesis. J. Virol. 2009, 83(18):9223-9236.
73. Moss B. Poxviridae: the viruses and their replication. Fields' Virology 2007, Vol. 2:2905-2945. Lippincott Williams and Wilkins, Philadelphia, PA, 2 vols. 5th ed. D.M. Knipe, P.M. Howley (Eds.).
74. O'Doherty U., Peng M., Gezelter S., Swiggard W.J., Betjes M., Bhardwaj N., Steinman R.M. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology 1994, 82(3):487-493.
75. O'Gorman W.E., Sampath P., Simonds E.F., Sikorski R., O'Malley M., Krutzik P.O., Chen H., Panchanathan V., Chaudhri G., Karupiah G., Lewis D.B., Thorne S.H., Nolan G.P. Alternate mechanisms of initial pattern recognition drive differential immune responses to related poxviruses. Cell Host Microbe 2010, 8(2):174-185.
76. Oie K., Pickup D. Cowpox virus and other members of the orthopoxvirus genus interfere with the regulation of NF-Κβ activation. Virology 2001, 288(1):175-187.
77. Osterrieder N., Meyer H., Pfeffer M. Characterization of the gene encoding the A-type inclusion body protein of mousepox virus. Virus Genes 1994, 8(2):125-135.
78. Panus J., Smith C., Ray C.A., Smith T., Patel D.D., Pickup D.J. Cowpox virus encodes a fifth member of the tumor necrosis factor receptor family: a soluble, secreted CD30 homologue. Proc. Natl Acad. Sci. USA 2002, 99:8348-8353.
79. Patel D.D., Pickup D.J., Joklik W.K. Isolation of cowpox virus A-type inclusions and characterization of their major protein component. Virology 1986, 149(2):174-189.
80. Pickup D.J. Understanding orthopoxvirus interference with host immune responses to inform novel vaccine design. Expert Rev. Vaccin. 2007, 6(1):87-95.
81. Pickup D., Ink B., Hu W., Ray C., Joklik W. Hemorrhage in lesions caused by cowpox virus is induced by a viral protein that is related toplasma protein inhibitors of serine proteases. Proc. Natl Acad. Sci. USA 1986, 83:7698-7702.
82. Ray C.A., Black R.A., Kronheim S.R., Greenstreet T.A., Sleath P.R., Salvesen G.S., Pickup D.J. Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1 beta converting enzyme. Cell 1992, 69(4):597-604.
83. Reed K.D., Melski J.W., Graham M.B., Regnery R.L., Sotir M.J., Wegner M.V., Kazmierczak J.J., Stratman E.J., Li Y., Fairley J.A., Swain G.R., Olson V.A., Sargent E.K., Kehl S.C., Frace M.A., Kline R., Foldy S.L., Davis J.P., Damon I.K. The detection of monkeypox in humans in the Western Hemisphere. N. Engl. J. Med. 2004, 350(4):342-350.
84. Samuelsson C., Hausmann J., Lauterbach H., Schmidt M., Akira S., Wagner H., Chaplin P., Suter M., O'Keeffe M., Hochrein H. Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection. J. Clin. Invest. 2008, 118(5):1776-1784.
85. Sanchez-Puig J.M., Sanchez L., Roy G., Blasco R. Susceptibility of different leukocyte cell types to Vaccinia virus infection. Virol. J. 2004, 1:10.
86. 2+-independent cell-matrix adhesion during the motile phase of infection. J. Virol. 1998, 72(12):9924-9933.
87. Sanderson C.M., Frischknecht F., Way M., Hollinshead M., Smith G.L. Roles of vaccinia virus EEV-specific proteins in intracellular actin tail formation and low pH-induced cell-cell fusion. J. Gen. Virol. 1998, 79(Pt 6):1415-1425.
88. Sanderson C.M., Way M., Smith G.L. Virus-induced cell motility. J. Virol. 1998, 72(2):1235-1243.
89. Schramm B., de Haan C.A., Young J., Doglio L., Schleich S., Reese C., Popov A.V., Steffen W., Schroer T., Locker J.K. Vaccinia-virus-induced cellular contractility facilitates the subcellular localization of the viral replication sites. Traffic 2006, 7(10):1352-1367.
90. Seet B.T., Johnston J.B., Brunetti C.R., Barrett J.W., Everett H., Cameron C., Sypula J., Nazarian S.H., Lucas A., McFadden G. Poxviruses and immune evasion. Annu. Rev. Immunol. 2003, 21:377-423.
91. Shisler J.L., Jin X.L. The vaccinia virus K1L gene product inhibits host NF-kappaB activation by preventing IkappaBalpha degradation. J. Virol. 2004, 78(7):3553-3560.
92. Siegal F.P., Kadowaki N., Shodell M., Fitzgerald-Bocarsly P.A., Shah K., Ho S., Antonenko S., Liu Y.J. The nature of the principal type 1 interferon-producing cells in human blood. Science 1999, 284(5421):1835-1837.
93. Smith C.A., Hu F.Q., Smith T.D., Richards C.L., Smolak P., Goodwin R.G., Pickup D.J. Cowpox virus genome encodes a second soluble homologue of cellular TNF receptors, distinct from CrmB, that binds TNF but not LT alpha. Virology 1996, 223(1):132-147.
94. Smith C.A., Smith T.D., Smolak P.J., Friend D., Hagen H., Gerhart M., Park L., Pickup D.J., Torrance D., Mohler K., Schooley K., Goodwin R.G. Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits beta chemokine activity yet lacks sequence homology to known chemokine receptors. Virology 1997, 236(2):316-327.
95. Smith V.P., Bryant N.A., Alcami A. Ectromelia, vaccinia and cowpox viruses encode secreted interleukin-18-binding proteins. J. Gen. Virol. 2000, 81(Pt 5):1223-1230.
96. Spriggs M.K., Hruby D.E., Maliszewski C.R., Pickup D.J., Sims J.E., Buller R.M., VanSlyke J. Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein. Cell 1992, 71(1):145-152.
97. Stack J., Haga I.R., Schroder M., Bartlett N.W., Maloney G., Reading P.C., Fitzgerald K.A., Smith G.L., Bowie A.G. Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence. J. Exp. Med. 2005, 201(6):1007-1018.
98. Symons J.A., Alcami A., Smith G. Vaccinia virus encode a soluble type I interferon receptor of novel structure and broad species specificity. Cell 1995, 81:551-560.
99. Tait S.W., Reid E.B., Greaves D.R., Wileman T.E., Powell P.P. Mechanism of inactivation of NF-kappa B by a viral homologue of I kappa b alpha. Signal-induced release of i kappa b alpha results in binding of the viral homologue to NF-kappa B. J. Biol. Chem. 2000, 275(44):34656-34664.
100. Turner P.C., Moyer R.W. An orthopoxvirus serpinlike gene controls the ability of infected cells to fuse. J. Virol. 1992, 66(4):2076-2085.
101. Vorou R.M., Papavassiliou V.G., Pierroutsakos I.N. Cowpox virus infection: an emerging health threat. Curr. Opin. Infect. Dis. 2008, 21(2):153-156.
102. Wagenaar T.R., Moss B. Association of vaccinia virus fusion regulatory proteins with the multicomponent entry/fusion complex. J. Virol. 2007, 81(12):6286-6293.
103. Wang N., Weber E., Blum J.S. Diminished intracellular invariant chain expression after vaccinia virus infection. J. Immunol. 2009, 183(3):1542-1550.
104. Ward B.M., Moss B. Vaccinia virus intracellular movement is associated with microtubules and independent of actin tails. J. Virol. 2001, 75(23):11651-11663.
105. Xia W., Pinto C.E., Kradin R.L. The antigen-presenting activities of Ia+ dendritic cells shift dynamically from lung to lymph node after an airway challenge with soluble antigen. J. Exp. Med. 1995, 181(4):1274-1283.
106. Yammani R.D., Pejawar-Gaddy S., Gurley T.C., Weimer E.T., Hiltbold E.M., Alexander-Miller M.A. Regulation of maturation and activating potential in CD8+ versus CD8+ dendritic cells following in vivo infection with vaccinia virus. Virology 2008, 378(1):142-150.
107. Yao Y., Li P., Singh P., Thiele A.T., Wilkes D.S., Renukaradhya G.J., Brutkiewicz R.R., Travers J.B., Luker G.D., Hong S.C., Blum J.S., Chang C.H. Vaccinia virus infection induces dendritic cell maturation but inhibits antigen presentation by MHC class II. Cell. Immunol. 2007, 246(2):92-102.
108. Yu Q., Hu N., Ostrowski M. Poxvirus tropism for primary human leukocytes and hematopoietic cells. Meth. Mol. Biol. 2009, 515:309-328.
109. Zhang X., Cassis-Ghavami F., Eller M., Currier J., Slike B.M., Chen X., Tartaglia J., Marovich M., Spearman P. Direct comparison of antigen production and induction of apoptosis by canarypox virus- and modified vaccinia virus ankara-human immunodeficiency virus vaccine vectors. J. Virol. 2007, 81(13):7022-7033.
110. Zhou J., Sun X.Y., Fernando G.J., Frazer I.H. The vaccinia virus K2L gene encodes a serine protease inhibitor which inhibits cell-cell fusion. Virology 1992, 189(2):678-686.
111. Zhu J., Martinez J., Huang X., Yang Y. Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-beta. Blood 2007, 109(2):619-625.